The effect of sex on responses to influenza vaccines

References

• Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Choen C, Gran JM, Schanzer D, Cowling BJ, Wu P, Kyncl J, Ang LW, Park M, Redlberger-Fritz M, Yu H, Espenhain L, Krishnan A, Emukule G, van Asten L, Pereira da Silva S, Aungkulanon S, Buchholz U, Widdowsen MA, Bresee JS. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285–300. doi:10.1016/S0140-6736(17)33293-2.
   PubMed Web of Science ®Google Scholar
• CDC Seasonal Flu Vaccine Effectiveness Studies. CDC. Available at: https://www.cdc.gov/flu/vaccines-work/effectiveness-studies.htm. (Accessed 16 March 2020)
   Google Scholar
• MMR Vaccination. What You Should Know | measles, Mumps, Rubella. CDC. Available at: https://www.cdc.gov/vaccines/vpd/mmr/public/index.html. (Accessed 16 March 2020)
   Google Scholar
• Paules CI, Fauci AS. Influenza vaccines: good, but we can do better. J. Infect. Dis. 2019;219(Supplement_1):S1–S4. doi:10.1093/infdis/jiy633.
   PubMedGoogle Scholar
• Edwards A. Annual National Flu programme letter 2019 to 2020. 2019.
   Google Scholar
• Baxter D. Evaluating the case for trivalent or quadrivalent influenza vaccines. Hum Vaccin Immunother. 2016;12(10):2712–17. doi:10.1080/21645515.2015.1091130.
   PubMed Web of Science ®Google Scholar
• Public Health England (PHE). Guidance. Summary of data to support the choice of influenza vaccination for adults in primary care. 2018.
   Google Scholar
• Van Buynder PG, Konrad S, Van Buynder JL, Brodkin E, Krajden M, Ramler G, Bigham M. The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly. Vaccine. 2013;31(51):6122–28. doi:10.1016/j.vaccine.2013.07.059.
   PubMed Web of Science ®Google Scholar
• Flanagan KL, Fink AL, Plebanski M, Klein SL. Sex and gender differences in the outcomes of vaccination over the life course. Annu. Rev. Cell Dev. Biol. 2017;33(1):577–99. doi:10.1146/annurev-cellbio-100616-060718.
   PubMed Web of Science ®Google Scholar
• Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010;10(5):338–49. doi:10.1016/S1473-3099(10)70049-9.
   PubMed Web of Science ®Google Scholar
• Markle JG, Fish EN. SeXX matters in immunity. Trends Immunol. 2014;35(3):97–104. doi:10.1016/j.it.2013.10.006.
   PubMed Web of Science ®Google Scholar
• Klein SL, Pekosz A. Sex-based biology and the rational design of influenza vaccination strategies. J. Infect. Dis. 2014;209(suppl 3):S114–S119. doi:10.1093/infdis/jiu066.
   PubMedGoogle Scholar
• Klein SL, Marriott I, Fish EN. Sex-based differences in immune function and responses to vaccination. Trans. R. Soc. Trop. Med. Hyg. 2014;109:9–15.
   Web of Science ®Google Scholar
• Van Der Laan JW, Herberts C, Lambkin-Williams R, Boyers A, Mann AJ, Oxford J. Animal models in influenza vaccine testing. Expert Rev Vaccines. 2008;7(6):783–93. doi:10.1586/14760584.7.6.783.
   PubMed Web of Science ®Google Scholar
• Huber VC, McKeon RM, Brackin MN, Miller LA, Keating R, Brown SA, Makarova N, Perez DR, MacDonald GH, McCullers JA, et al. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Clin. Vaccine Immunol. 2006;13(9):981–90. doi:10.1128/CVI.00156-06.
   PubMed Web of Science ®Google Scholar
• Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatric Infect Dis J. 2001;20(1):63–75. doi:10.1097/00006454-200101000-00013.
   PubMed Web of Science ®Google Scholar
• Živković I, Bufan B, Petrušić V, Minić R, Arsenović-Ranin N, Petrović R, Leposavić G. Sexual diergism in antibody response to whole virus trivalent inactivated influenza vaccine in outbred mice. Vaccine. 2015;33(42):5546–52. doi:10.1016/j.vaccine.2015.09.006.
   PubMed Web of Science ®Google Scholar
• Živković I, Petrović R, Arsenović-Ranin N, Petrušić V, Minić R, Bufan B, Popović O, Leposavić G. Sex bias in mouse humoral immune response to influenza vaccine depends on the vaccine type. Biologicals. 2018;52:18–24. doi:10.1016/j.biologicals.2018.01.007.
   PubMed Web of Science ®Google Scholar
• Petrović R, Bufan B, Arsenović-Ranin N, Živković I, Minić R, Radojević K, Leposavić G. Mouse strain and sex as determinants of immune response to trivalent influenza vaccine. Life Sci. 2018;207:117–26. doi:10.1016/j.lfs.2018.05.056.
   PubMed Web of Science ®Google Scholar
• Arsenović-Ranin N, Petrović R, Živković I, Bufan B, Stoiljković V, Leposavić G. Influence of aging on germinal centre reaction and antibody response to inactivated influenza virus antigens in mice: sex-based differences. Biogerontology. 2019;20(4):475–96. doi:10.1007/s10522-019-09811-8.
   PubMed Web of Science ®Google Scholar
• Fink AL, Engle K, Ursin RL, Tang WY, Klein SL. Biological sex affects vaccine efficacy and protection against influenza in mice. Proc. Natl. Acad. Sci. U. S. A. 2018;115(49):12477–82. doi:10.1073/pnas.1805268115.
   PubMed Web of Science ®Google Scholar
• Potluri T, Fink AL, Sylvia KE, Dhakal S, Vermillion MS, vom Steeg L, Deshpande S, Narasimhan H, Klein SL. Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females. Npj Vaccines. 2019;4.
   Web of Science ®Google Scholar
• Lorenzo ME, Hodgson A, Robinson DP, Kaplan JB, Pekosz A, Klein SL. Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 mice. Vaccine. 2011;29(49):9246–55. doi:10.1016/j.vaccine.2011.09.110.
   PubMed Web of Science ®Google Scholar
• Luke CJ, Subbarao K. The role of animal models in influenza vaccine research. Influenza vaccines for the future, 161–202. Birkhäuser Basel. 2008. 10.1007/978-3-7643-8371-8_8
   Google Scholar
• Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thiebaut R, Tibshirani RJ, Davis MM. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc. Natl. Acad. Sci. U. S. A. 2014;111(2):869–74. doi:10.1073/pnas.1321060111.
   PubMed Web of Science ®Google Scholar
• Cook IF, Barr I, Hartel G, Pond D, Hampson AW. Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults. Vaccine. 2006;24(13):2395–402. doi:10.1016/j.vaccine.2005.11.057.
   PubMed Web of Science ®Google Scholar
• Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ. Randomized, double‐blind controlled phase 3 trial comparing the immunogenicity of high‐dose and standard‐dose influenza vaccine in adults 65 years of age and older. J. Infect. Dis. 2009;200(2):172–80. doi:10.1086/599790.
   PubMed Web of Science ®Google Scholar
• Hara M, Hanaoka T, Maeda K, Kase T, Ohfuji S, Fukushima W, Hirota Y. Immunogenicity and efficacy of A/H1N1pdm vaccine among subjects with severe motor and intellectual disability in the 2010/11 influenza season. J. Epidemiol. 2016;26(6):300–06. doi:10.2188/jea.JE20150036.
   PubMed Web of Science ®Google Scholar
• Talaat KR, Greenberg M, Lai M, Hartel G, Wichems C, Rockman S, Jeanfreau R, Ghosh M, Kabongo M, Gittleson C, et al. A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults. J. Infect. Dis. 2010;202(9):1327–37. doi:10.1086/656601.
   PubMed Web of Science ®Google Scholar
• Fink AL, Klein SL. Sex and gender impact immune responses to vaccines among the elderly. Physiology. 2015;30(6):408–16. doi:10.1152/physiol.00035.2015.
   PubMed Web of Science ®Google Scholar
• Looker C, Luster MI, Calafat AM, Johnson VJ, Burleson GR, Burleson FG, Fletcher T. Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate. Toxicol. Sci. 2014;138(1):76–88. doi:10.1093/toxsci/kft269.
   PubMed Web of Science ®Google Scholar
• Jackson LA, Gaglani MJ, Keyserling HL, Balser J, Bouveret N, Fries L, Treanor JJ. Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: A randomized, placebo-controlled trial over two influenza seasons. BMC Infect. Dis. 2010;10(1). doi:10.1186/1471-2334-10-71.
   Google Scholar
• Olafsdottir TA, Alexandersson KF, Sveinbjornsson G, Lapini G, Palladino L, Montomoli E, Del Giudice G, Gudbjartsson DF, Jonsdottir I. Age and influenza-specific pre-vaccination antibodies strongly affect influenza vaccine responses in the icelandic population whereas disease and medication have small effects. Front. Immunol. 2018;8:1872. doi:10.3389/fimmu.2017.01872.
   PubMed Web of Science ®Google Scholar
• Hagihara Y, Ohfuji S, Watanabe K, Yamagami H, Fukushima, W, Maeda K, Kamata N, Sogawa M, Shiba M, Tanigawa T, Tominaga K, Watanabe T, Fujiwara Y, Hirota Y, Arakawa T. Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease. J. Crohn’s Colitis. 2014;8(3):223–33. doi:10.1016/j.crohns.2013.08.008.
   Google Scholar
• Rapezzi D, Sticchi L, Racchi O, Mangerini R, Ferraris AM, Gaetani GF. Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma. Eur. J. Haematol. 2003;70(4):225–30. doi:10.1034/j.1600-0609.2003.00028.x.
   PubMed Web of Science ®Google Scholar
• Gorse GJ, Falsey AR, Ozol-Godfrey A, Landolfi V, Tsang PH. Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults. Vaccine. 2015;33(9):1151–59. doi:10.1016/j.vaccine.2015.01.025.
   PubMed Web of Science ®Google Scholar
• Coleman BL, McGeer AJ, Halperin SA, Langley JM, Shamout Y, Taddio A, Shah V, McNeil SA. A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine. Vaccine. 2012;30(44):6287–93. doi:10.1016/j.vaccine.2012.08.006.
   PubMed Web of Science ®Google Scholar
• Nakaya HI, Hagan T, Duraisingham S, Lee E, Kwissa M, Rouphael N, Frasca D, Gersten M, Mehta A, Gaujoux R, et al. Systems analysis of immunity to influenza vaccination across multiple years and in diverse populations reveals shared molecular signatures. Immunity. 2015;43(6):1186–98. doi:10.1016/j.immuni.2015.11.012.
   PubMed Web of Science ®Google Scholar
• Moynihan JA, Larson MR, Treanor J, Duberstein PR, Power A, Shore B, Ader R. Psychosocial factors and the response to influenza vaccination in older adults. Psychosom. Med. 2004;66(6):950–53. doi:10.1097/01.psy.0000140001.49208.2d.
   PubMed Web of Science ®Google Scholar
• Strindhall J, Ernerudh J, Mörner A, Waalen K, Löfgren S, Matussek A, Bengner M. Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4/CD8 ratio. Infect. Dis. (Auckl). 2016;48(6):436–42. doi:10.3109/23744235.2015.1135252.
   PubMed Web of Science ®Google Scholar
• Govaert TME, Sprenger MJW, Dinant GJ, Aretz K, Masurel N, Knottnerus JA. Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial. Vaccine. 1994;12(13):1185–89. doi:10.1016/0264-410X(94)90241-0.
   PubMed Web of Science ®Google Scholar
• Barrett PN, Berezuk G, Fritsch S, Aichinger G, Hart MK, El-Amin W, Kistner O, Ehrlich HJ. Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: A multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2011;377(9767):751–59. doi:10.1016/S0140-6736(10)62228-3.
   PubMed Web of Science ®Google Scholar
• Rivera L, Mazara S, Vargas M, Fragapane E, Casula D, Groth N. Phase III, randomized controlled trial to evaluate lot consistency of a trivalent subunit egg-based influenza vaccine in adults. Vaccine. 2012;30(35):5285–92. doi:10.1016/j.vaccine.2012.05.021.
   PubMed Web of Science ®Google Scholar
• Tadount F, Doyon-Plourde P, Rafferty E, MacDonald S, Sadarangani M, Quach C. Is there a difference in the immune response, efficacy, effectiveness and safety of seasonal influenza vaccine in males and females? – A systematic review. Vaccine. 2019. doi:10.1016/j.vaccine.2019.10.091.
   Web of Science ®Google Scholar
• Ferdinands JM, Shay DK. Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination. Clin. Infect. Dis. 2012;54(1):25–32. doi:10.1093/cid/cir750.
   PubMed Web of Science ®Google Scholar
• Voysey M, Pollard AJ, Perera R, Fanshawe TR. Assessing sex-differences and the effect of timing of vaccination on immunogenicity, reactogenicity and efficacy of vaccines in young children: study protocol for an individual participant data meta-analysis of randomised controlled trials. BMJ Open. 2016;6(7):e011680. doi:10.1136/bmjopen-2016-011680.
   PubMed Web of Science ®Google Scholar
• Mosterín Höpping A, McElhaney J, Fonville JM, Powers DC, Beyer WEP, Smith DJ. The confounded effects of age and exposure history in response to influenza vaccination. Vaccine. 2016;34(4):540–46. doi:10.1016/j.vaccine.2015.11.058.
   PubMed Web of Science ®Google Scholar
• How Flu Vaccine Effectiveness and Efficacy are Measured. CDC. Available at: https://www.cdc.gov/flu/vaccines-work/effectivenessqa.htm. (Accessed 1 January 2020)
   Google Scholar
• Mcneil S. Overview of vaccine efficacy and vaccine effectiveness.
   Google Scholar
• Mori M, Oura A, Ohnishi H, Washio M. Confounding in evaluating the effectiveness of influenza vaccine. Vaccine. 2008;26(50):6459–61. doi:10.1016/j.vaccine.2008.06.040.
   PubMed Web of Science ®Google Scholar
• Vila-Córcoles A, Rodriguez T, de Diego C, Ochoa O, Valdivieso A, Salsench E, Ansa X, Badía W, Saún N. Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods. Vaccine. 2007;25(37–38):6699–707. doi:10.1016/j.vaccine.2007.07.015.
   PubMed Web of Science ®Google Scholar
• Fleming DM, Watson JM, Nicholas S, Smith GE, Swan AV. Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989–90 using a general practice database. Epidemiol. Infect. 1995;115:581–89.
   PubMed Web of Science ®Google Scholar
• Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N. Engl. J. Med. 2007;357:1373–81.
   PubMed Web of Science ®Google Scholar
• Nichol KL. Heterogeneity of influenza case definitions and implications for interpreting and comparing study results. Vaccine. 2006;24(44–46):6726–28. doi:10.1016/j.vaccine.2006.05.064.
   PubMed Web of Science ®Google Scholar
• Kwong JC, Campitelli MA, Gubbay JB, Peci A, Winter A-L, Olsha R, Turner R, Rosella LC, Crowcroft NS. Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season. Clin. Infect. Dis. 2013;57(6):820–27. doi:10.1093/cid/cit404.
   PubMed Web of Science ®Google Scholar
• Talbot HK, Griffin MR, Chen Q, Zhu Y, Williams JV, Edwards KM. Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. J. Infect. Dis. 2011;203(4):500–08. doi:10.1093/infdis/jiq076.
   PubMed Web of Science ®Google Scholar
• Trebbien R, Fischer TK, Krause TG, Nielsen L, Nielsen XC, Weinreich LS, Lis-Tønder J, Skov MN, Christiansen CB, Emborg H-D, et al. Changes in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016/17 season in Denmark. J. Clin. Virol. 2017;94:1–7. doi:10.1016/j.jcv.2017.06.007.
   PubMed Web of Science ®Google Scholar
• Gilca R, Skowronski DM, Douville-Fradet M, Amini R, Boulianne N, Rouleau I, Martineau C, Charest H, De Serres G. Mid-Season estimates of influenza vaccine effectiveness against influenza A(H3N2) hospitalization in the elderly in Quebec, Canada, January 2015. PLoS One. 2015;10(7):e0132195. doi:10.1371/journal.pone.0132195.
   PubMed Web of Science ®Google Scholar
• Bragstad K, Emborg HD, Fischer TK, Voldstedlund M, Gubbels S, Andersen B, Molbak K, Krause TG. Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13 - A rapid epidemiological and virological assessment. Eurosurveillance. 2013;18:20397.
   Web of Science ®Google Scholar
• Emborg HD, Krause TG, Nielsen L, Thomsen MK, Christiansen CB, Skov MN, Nielsen XC, Weinreich LS, Fischer TK, Rønn J, et al. Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16 – a rapid epidemiological and virological assessment. Eurosurveillance. 2016;21(14):30189. doi:10.2807/1560-7917.ES.2016.21.14.30189.
   Web of Science ®Google Scholar
• Galdas PM, Cheater F, Marshall P. Men and health help-seeking behaviour: literature review. J Adv Nurs. 2005;49(6):616–23. doi:10.1111/j.1365-2648.2004.03331.x.
   PubMed Web of Science ®Google Scholar
• Trombetta CM, Gianchecchi E, Montomoli E. Influenza vaccines: evaluation of the safety profile. Hum Vaccin Immunother. 2018;14(3):657–70. doi:10.1080/21645515.2017.1423153.
   PubMed Web of Science ®Google Scholar
• Li R, Stewart B, McNeil MM, Duffy J, Nelson J, Kawai AT, Baxter R, Belongia EA, Weintraub E. Post licensure surveillance of influenza vaccines in the vaccine safety datalink in the 2013–2014 and 2014–2015 seasons. Pharmacoepidemiol. Drug Saf. 2016;25(8):928–34. doi:10.1002/pds.3996.
   PubMed Web of Science ®Google Scholar
• Schmid P, Rauber D, Betsch C, Lidolt G, Denker ML. Barriers of influenza vaccination intention and behavior - A systematic review of influenza vaccine hesitancy, 2005-2016. PLoS ONE. 2017;12.
   Web of Science ®Google Scholar
• Marti M, de Cola M, MacDonald NE, Dumolard L, Duclos P. Assessments of global drivers of vaccine hesitancy in 2014—Looking beyond safety concerns. PLoS One. 2017;12:e0172310.
   PubMed Web of Science ®Google Scholar
• Engler RJM, Nelson MR, Klote MM, VanRaden MJ, Huang C, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, Treanor JT. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch. Intern. Med. 2008;168(22):2405–14. doi:10.1001/archinternmed.2008.513.
   PubMedGoogle Scholar